Health Care/Hospital

Akeso Announced NDA Acceptance of IL-12/lL-23 Monoclonal Antibody Ebdarokimab for Moderate-to-severe Plaque Psoriasis by China NMPA

HONG KONG, Aug. 24, 2023 /PRNewswire/ -- Akeso Inc. ("Akeso", the "Company"; 9926.HK), a commercial-stage biopharmaceutical company focused on developing and commercializing first-in-class and best-in-class innovative medicines globally, announced today that the New Drug Application (NDA) for its...

2023-08-24 20:00 1407

Zhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease Management

SHANGHAI, Aug. 24, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced it has achieved a milestone of serving over 10,000 breast cancer ...

2023-08-24 20:00 1611

Vittra APS Unique composite by FGM is appointed as a solution to a clinical problem by the renowned agency Dental Advisor

JOINVILLE, Brazil, Aug. 24, 2023 /PRNewswire/ -- The Vittra APS Unique composite, by FGM Dental Group, was recognized for its chameleon effect in the publication Clinical Problem Solvers of the renowned American agency Dental Advisor - a global reference in the field of dentistry. In the publicat...

2023-08-24 18:00 1525

111, Inc. Announces Second Quarter 2023 Unaudited Financial Results

SHANGHAI, Aug. 24, 2023 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced its unaudited financial results for the second quar...

2023-08-24 14:00 3003

MRI Software's first 'Voice of the Strata Manager' report reveals unseen pressures of high-demand real estate industry job

Despite dealing with difficult behaviour from owners and 50+ hour work weeks, strata managers are optimistic about the future of their jobs and industry SYDNEY, Aug. 24, 2023 /PRNewswire/ -- A new national 'Voice of the Strata Manager' report reveals an alarming number of Australian strata manage...

2023-08-24 13:02 2319

PeptiGrowth Inc. and Orizuru Therapeutics, Inc. Enter into Joint Development of Novel Synthetic Peptide Based Growth Factor

TOKYO, Aug. 23, 2023 /PRNewswire/ -- PeptiGrowth Inc (PeptiGrowth), a Japanese biotechnology company focusing on the development of synthetic peptide based growth factors and Orizuru Therapeutics, Inc(OZTx), a Japanese biopharmaceutical company focusing on the research and development of iPSC-de...

2023-08-24 09:51 1374

Everest Medicines Announces Interim Results for First Half of 2023

SHANGHAI, Aug. 24, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, today announced its interim results for the first half of 2023, ...

2023-08-24 08:15 3617

Samsung Biologics appoints new leadership to oversee quality and regulatory affairs

- Distinguished industry leaders with extensive track records in quality assurance and regulatory affairs join Samsung Biologics to support the company's quality-driven business operation. INCHEON, South Korea, Aug. 23, 2023 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global contract d...

2023-08-24 07:59 1469

Salvia BioElectronics: First-Ever Patient Treated with Breakthrough Neuromodulation Solution for Severe Migraine and Cluster Headache in Australia

NAMBOUR, Australia, Aug. 24, 2023 /PRNewswire/ -- In a remarkable medical milestone, an Australian patient at Nambour Selangor Private Hospital became the first-ever patient to receive Salvia BioElectronics' paper-thin neuromodulation solution for severe migraine and cluster headache. This groun...

2023-08-24 05:45 1524

Jin Medical International Limited (NASDAQ: ZJYL) Announces Financial Results for Six Months Ended March 31, 2023

CHANGZHOU, China, Aug. 23, 2023 /PRNewswire/ -- Jin Medical International Limited ("the Company" or "JinMed") (NASDAQ: ZJYL), aCayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, today announced its financial results fo...

2023-08-24 04:15 2776

Sisram Medical Announces First-Half 2023 Financial Results

Expanding Sisram's Ecosystem Offerings and Increasing Direct Sales Reach HONG KONG, Aug. 24, 2023 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global consumer wellness group, featuring a distingu...

2023-08-24 00:50 3357

Complete Genomics Garners the Prestigious 2023 R&D 100 Awards for Cutting-Edge Innovation

SAN JOSE, Calif., Aug. 23, 2023 /PRNewswire/ -- Complete Genomics, Inc., a pioneering genomic sequencing company, today proudly received the honor of the R&D 100 Awards from R&D World Magazine, often referred to as the "Oscars of Innovation". Widely recognized in industry, government, and academ...

2023-08-23 23:00 1304

Optum Applauded by Frost & Sullivan for Advancing the Use of Real-World Evidence by Life Sciences Companies and for Its Market-leading Position

With a legacy of industry leadership, Optum offers a compelling value proposition and innovative solutions that effectively address market gaps, underpinning its sustained success. SAN ANTONIO, Aug. 23, 2023 /PRNewswire/ -- Frost & Sullivan recently assessed the landscape for real-world evidence...

2023-08-23 22:00 1565

IMG Appoints Justin Poehler as Chief Commercial Officer

INDIANAPOLIS, Aug. 23, 2023 /PRNewswire/ -- IMG (International Medical Group), an award-winning global insurance benefits and assistance services company, is pleased to announce thatJustin Poehler, formerly the Vice President of Marketing and Ecommerce, has been appointed as Chief Commercial Offi...

2023-08-23 21:00 1204

CHINA LIFE INSURANCE COMPANY LIMITED ANNOUNCES 2023 INTERIM RESULTS (H SHARES)

HONG KONG, Aug. 23, 2023 /PRNewswire/ -- China Life Insurance Company Limited (SSE: 601628, SEHK: 2628) announces the unaudited consolidated results of the Company (China Life Insurance Company Limited and its subsidiaries) for the six months ended30 June 2023 (the "Reporting Period") prepared un...

2023-08-23 20:34 3021

Crystal S. Denlinger, MD, FACP, Named New CEO of National Comprehensive Cancer Network; Robert W. Carlson, MD, Retiring After 10+ Years Leading Global Oncology Nonprofit

Dr. Denlinger is currently NCCN's Chief Scientific Officer and previously served as Chair and Member of multiple NCCN Guidelines Panels—in charge of maintaining gold-standard evidence-based expert consensus cancer treatment recommendations. PLYMOUTH MEETING, Pa., Aug. 23, 2023 /PRNewswire/ -- To...

2023-08-23 20:06 1366

Food Science, which developed the world's first hangover drink with the protein of blowfish, launches the fruit-flavored carbonated drink 'VTalk Ade'

* The company was selected as a beneficiary of early-stage technology commercialization investment by Korea Development Bank SEOUL, South Korea, Aug. 23, 2023 /PRNewswire/ -- Food Science, selected by the Ministry of SMEs and Startups as one of 30 companies to participate in this year's Social ...

2023-08-23 20:00 771

Innovent Announces 2023 Interim Results and Business Updates

Remarkable achievements with accelerated growth and improved efficiency to underpin sustainable growth ROCKVILLE, M.D. and SUZHOU, China, Aug. 23, 2023 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and comme...

2023-08-23 19:38 4262

Dizal's Sunvozertinib Approved by China NMPA with Potential for Best-in-class Therapy in NSCLC with EGFR Exon20ins Mutations

* Sunvozertinib, a selective EGFR TKI targeting a wide spectrum of EGFR mutations, is the first Chinese Innovative drug approved for NSCLC Patients with EGFR Exon20ins * Approval based on the results of primary endpoint from WU-KONG6 study, which demonstrated a superior confirmed objective re...

2023-08-23 19:21 790

Trisol announces successful implants of its Transcatheter Tricuspid Valve in the US

Two implants were successfully conducted as part of the FDA approved Early Feasibility Study inthe United States YOKNEAM, Israel, Aug. 23, 2023 /PRNewswire/ -- The heart teams at the Piedmont Heart Institute inAtlanta, Georgia, USA and the University of Virginia Health System inCharlottesville, ...

2023-08-23 18:07 1048
1 ... 132133134135136137138 ... 817